yttrium Y 90-DOTA monoclonal antibody HuPAM4
Term · Oncology and biomedicine · MLC-T-ONC-009448
A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 contains a monoclonal antibody that binds to a protein called MUC-1, which is found on some pancreatic cancer cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 is a type of radioimmunoconjugate. Also called yttrium Y 90-clivatuzumab tetraxetan.
| Identifier | MLC-T-ONC-009448 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | yttrium Y 90-clivatuzumab tetraxetan |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009448",
"term": "yttrium Y 90-DOTA monoclonal antibody HuPAM4",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 contains a monoclonal antibody that binds to a protein called MUC-1, which is found on some pancreatic cancer cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 is a type of radioimmunoconjugate. Also called yttrium Y 90-clivatuzumab tetraxetan.",
"synonyms": [
"yttrium Y 90-clivatuzumab tetraxetan"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/yttrium-y-90-dota-monoclonal-antibody-hupam4/"
}
Record 17,578 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.